Erratum
1
Erratum Yang Z-Y, Wu X-Y, Huang Y-F, Di M-Y, Zheng D-Y, Chen J-Z, Ding H, Mao C, Tang J-L. Promising biomarkers for predict- ing the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis. Int J Cancer. 2013 October 15;133(8):1914–1925 doi: 10.1002/ijc.28153. Epub 2013 Nov 11. An error occurred in the Abstract. The sentence reading: “These results suggest that BRAF mutations, PIK3CA exon 20 muta- tions and PTEN loss are predictive of better outcomes in KRAS wild-type mCRC treated with anti-EGFR MoAbs.” should have read “These results suggest that BRAF mutations, PIK3CA exon 20 mutations and PTEN loss are predictive of worse outcomes in KRAS wild-type mCRC treated with anti-EGFR MoAbs.” The authors regret this error. DOI: 10.1002/ijc.28820 Erratum Int. J. Cancer: 135, E2 (2014) V C 2014 UICC International Journal of Cancer IJC
-
Upload
nguyenthien -
Category
Documents
-
view
212 -
download
0
Transcript of Erratum
Erratum
Yang Z-Y, Wu X-Y, Huang Y-F, Di M-Y, Zheng D-Y, Chen J-Z, Ding H, Mao C, Tang J-L. Promising biomarkers for predict-ing the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factorreceptor monoclonal antibodies: A systematic review with meta-analysis. Int J Cancer. 2013 October 15;133(8):1914–1925doi: 10.1002/ijc.28153. Epub 2013 Nov 11.
An error occurred in the Abstract. The sentence reading: “These results suggest that BRAF mutations, PIK3CA exon 20 muta-tions and PTEN loss are predictive of better outcomes in KRAS wild-type mCRC treated with anti-EGFR MoAbs.” shouldhave read “These results suggest that BRAF mutations, PIK3CA exon 20 mutations and PTEN loss are predictive of worseoutcomes in KRAS wild-type mCRC treated with anti-EGFR MoAbs.” The authors regret this error.
DOI: 10.1002/ijc.28820
Erratum
Int. J. Cancer: 135, E2 (2014) VC 2014 UICC
International Journal of Cancer
IJC
